Search

everythinglearnresearchcommunity

for

Search:↓

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Intradermal PRP significantly improved melasma in dark skin, with lasting results and no relapse after 3 months.

The document concludes that available medical treatments for common hair loss disorders are generally safe and effective, and the emotional impact of hair loss should be considered in treatment plans.

Cannabinoids may help some skin conditions but more research is needed.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Alopecia areata affects self-esteem and social life, but new treatments offer hope.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

A woman with severe hair loss regrew mostly white hair after treatment.

Dravanti beeja lepa is safe and effective for regrowing hair in Alopecia Areata.

The document concludes that hair loss in women is treated with medications, therapies, and surgery in Western medicine, and with acupuncture and herbs in Chinese medicine, but hereditary hair loss is hard to reverse.

New research is helping develop better treatments for alopecia areata.

Early, tailored assessment and treatment are crucial for adolescent hair loss, with promising new diagnostic and treatment options.

Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.

Individualized homeopathic treatment may help improve hair loss and well-being in people with alopecia areata.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

A single PRP treatment makes facial skin look younger and improves satisfaction.

Hair loss can be treated based on its type and cause, improving quality of life.

An integrated approach can help treat childhood alopecia areata.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Micro needling is a skin treatment that helps with various skin conditions including stretch marks, by boosting collagen production, but it may cause redness and irritation.

Platelet-rich plasma treatment is generally safe and effective for hair loss, acne scars, skin discoloration, and facial rejuvenation, but deeper injections are better and multiple treatments can increase risk of side effects.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

A girl's hair loss was found to be caused by both a hair-pulling disorder and another hair loss condition.